Warner Babcock Forms Drug Technology Firm | Chemical & Engineering News
Volume 89 Issue 44 | p. 21 | Concentrates
Issue Date: October 31, 2011

Warner Babcock Forms Drug Technology Firm

Department: Business
Keywords: drug delivery, venture capital, green chemistry

The Warner Babcock Institute for Green Chemistry has joined with the venture capital firm Elm Street Ventures to form Occam Sciences, a New Haven, Conn.-based company that will develop new forms of existing drugs with optimized bioavailability. Occam is based on WBI’s noncovalent derivatization technology, which alters selected physical properties in target drugs. WBI CEO Joe Pont says the technology has already been successfully commercialized in other industries.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment